Friday, February 12, 2016

Tarsa Therapeutics raises $28M in capital

The latest equity financing brings the total amount of venture capital invested in the Philadelphia drug development firm to $76.6 million.

Tarsa Therapeutics raises $28M in capital

0 comments

Tarsa Therapeutics Inc., a Philadelphia drug development firm, raised $28 million from four venture capital firms.
The company is preparing to file a New Drug Application with the U.S. Food and Drug Administration later this year to seek approval for an osteoporosis treatment called Ostara.
Tarsa, which has 12 full-time employees in its Center City offices, has raised a total of $76.6 million since its founding in the fall of 2009.
Foresite Capital was the lead investor in the latest equity financing for Tarsa, which also received funds from current investors Novo A/S, MVM Life Science Partners and Philadelphia’s Quaker Partners.
Inquirer Columnist
0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog
Mike Armstrong blogs about Philadelphia corporations and business-related topics. Contact him at 215-854-2980. Reach Mike at marmstrong@phillynews.com.

Mike Armstrong Inquirer Columnist
Also on Philly.com:
letter icon Newsletter